Bioherent — Seed · €2.9M

Bioherent, a University of Málaga spin-off founded in July 2021 that has built an integrated photonic biosensor for in vitro diagnosis of beta-lactam antibiotic allergies, raised a €2.9M round to run clinical validation and prepare market entry. CDTI committed €1,365,000 through its Innvierte programme alongside Bullnet Capital; no lead was stated.